SALOMONE, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 8.000
EU - Europa 3.134
AS - Asia 2.830
SA - Sud America 649
AF - Africa 438
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 15.069
Nazione #
US - Stati Uniti d'America 7.723
SG - Singapore 1.271
CN - Cina 1.082
IT - Italia 975
IE - Irlanda 724
UA - Ucraina 613
BR - Brasile 569
CI - Costa d'Avorio 251
CA - Canada 245
RU - Federazione Russa 201
DE - Germania 172
VN - Vietnam 141
SN - Senegal 128
SE - Svezia 110
GB - Regno Unito 68
IN - India 66
KR - Corea 65
FI - Finlandia 49
FR - Francia 46
JP - Giappone 29
BD - Bangladesh 27
AR - Argentina 23
NL - Olanda 22
BE - Belgio 21
ZA - Sudafrica 21
CH - Svizzera 20
ID - Indonesia 20
MX - Messico 19
PL - Polonia 18
EC - Ecuador 17
TR - Turchia 17
UZ - Uzbekistan 17
ES - Italia 16
GR - Grecia 14
IQ - Iraq 14
AT - Austria 12
CZ - Repubblica Ceca 12
IR - Iran 12
PK - Pakistan 12
CO - Colombia 11
HK - Hong Kong 11
AU - Australia 10
MA - Marocco 10
LB - Libano 9
PY - Paraguay 9
EG - Egitto 7
EU - Europa 7
LT - Lituania 7
AL - Albania 6
AZ - Azerbaigian 6
BG - Bulgaria 6
IL - Israele 6
TN - Tunisia 6
VE - Venezuela 6
HR - Croazia 5
KE - Kenya 5
NG - Nigeria 5
AE - Emirati Arabi Uniti 4
JM - Giamaica 4
PE - Perù 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
DO - Repubblica Dominicana 3
RS - Serbia 3
SA - Arabia Saudita 3
AO - Angola 2
BO - Bolivia 2
CL - Cile 2
CR - Costa Rica 2
GA - Gabon 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LU - Lussemburgo 2
OM - Oman 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GF - Guiana Francese 1
IM - Isola di Man 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SR - Suriname 1
SV - El Salvador 1
Totale 15.069
Città #
Dallas 1.417
Santa Clara 1.019
Chandler 916
Singapore 762
Dublin 723
Jacksonville 686
Chicago 331
Boardman 325
Catania 285
Abidjan 251
Ashburn 215
Cambridge 200
Lawrence 198
Andover 195
Nanjing 180
Toronto 169
Houston 168
Beijing 167
Hefei 163
Dakar 128
Wilmington 110
Des Moines 87
Los Angeles 84
Civitanova Marche 83
San Mateo 83
Dong Ket 65
Seoul 65
Shenyang 63
Nanchang 62
Council Bluffs 57
Grafing 53
Hebei 51
Ottawa 49
The Dalles 49
Bremen 47
São Paulo 47
Saint Petersburg 45
Columbus 44
Messina 41
Changsha 38
New York 36
Jiaxing 35
Munich 30
Tianjin 30
Ho Chi Minh City 29
Palermo 28
Falls Church 27
Seattle 25
Tokyo 25
Dearborn 22
Hanoi 21
Helsinki 21
Rio de Janeiro 21
Rome 21
Norwalk 19
Brooklyn 17
Florence 17
Milan 17
Redwood City 17
Atlanta 16
Jinan 16
Turku 16
Lissone 15
Moscow 15
Brussels 14
Curitiba 14
Pune 14
Stockholm 14
Belo Horizonte 13
Hangzhou 13
Denver 12
Guangzhou 12
Johannesburg 12
Kunming 12
Liberty Lake 12
Montreal 12
Washington 12
Boston 11
Irvine 11
Mumbai 11
Buffalo 10
Campinas 10
Chennai 10
Ningbo 10
Padova 10
Phoenix 10
Tappahannock 10
Warsaw 10
Amsterdam 9
Campobasso 9
San Francisco 9
Sesto Fiorentino 9
Turin 9
Jakarta 8
Lappeenranta 8
Orem 8
Recife 8
Redondo Beach 8
Vicenza 8
Baghdad 7
Totale 10.636
Nome #
A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice 223
Current drug treatments targeting dopamine D3 receptor 196
Dopaminergic-GABAergic interplay and alcohol binge drinking 182
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway 175
Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1 159
Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial. 137
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 135
Anti-VEGF agents inhibit activation of PLA2/COX-2 and expression of VEGF-A induced by high glucose, in human retinal pericytes in vitro 135
Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy 134
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 131
Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease 129
Apixaban enhances vasodilatation mediated by protease-activated receptor 2 in isolated rat arteries 128
A new human blood–retinal barrier model based on endothelial cells, pericytes, and astrocytes 127
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 126
1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats 125
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 125
Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3receptor blockade 124
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 122
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 115
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 115
Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders 113
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 108
Epigenetic drugs for Alzheimer's disease: hopes and challenges 108
Blink reflex recovery cycle to differentiate progressive supranuclear palsy from corticobasal syndrome 108
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 106
Particle identification with the 4 pi CHIMERA detector array 106
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 102
Controversies in Glaucoma: Current Medical Treatment and Drug Development 101
Effects of phenformin on the proliferation of human tumor cell lines 100
P2X7 receptor antagonism: implications in diabetic retinopathy 98
Clinical course of N-methyl-D-aspartate receptor encephalitis and the effectiveness of cyclophosphamide treatment 98
Off-label use of drugs and adverse drug reactions in pediatric units: A prospective, multicenter study 98
Ambiguities in dietary antioxidant supplementation compared to calcium channel blockers therapy 97
Dopamine D3 Receptor, Cognition and Cognitive Dysfunctions in Neuropsychiatric Disorders: From the Bench to the Bedside 96
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 96
Isoflavones: estrogenic activity, biological effect and bioavailability 95
Activity of dihydrothienopyridine S312 enantiomers on L-type calcium channels in isolated rat aorta and cerebral microvessels 95
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 94
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 94
Gut microbiota alterations promote traumatic stress susceptibility associated with p-cresol-induced dopaminergic dysfunctions 93
Dysregulation of miR-15a-5p, miR-497a-5p and miR-511-5p Is Associated with Modulation of BDNF and FKBP5 in Brain Areas of PTSD-Related Susceptible and Resilient Mice 92
Sphingosine-1-phosphate and Sphingosine-1-phosphate receptors in the cardiovascular system: pharmacology and clinical implications 90
Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution 90
A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin 90
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 89
Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation 89
PLGA-PEG NANOPARTICLES LOADED WITH ANTIPSYCHOTIC AGENTS: INFLUENCE OF DRUG MOLECULES ON THE CRYOPROTECTIVE EFFECT OF SUCROSE. 89
Retinal protection and distribution of curcumin in vitro and in vivo 89
Isolation, cultivation, and characterization of primary bovine cochlear pericytes: A new in vitro model of stria vascularis 89
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: analyses in patients and perinatal Δ9-tetrahydrocannabinol-exposed rats 89
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 88
Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline 88
Pleiotropic effects of glitazones: a double edge sword? 87
Evaluation of Neostigmine responsiveness with concentric-needle single fiber electromyography in myasthenia gravis: A comparative study 87
MicroRNAs in the vitreous humor of patients with retinal detachment and a different grading of proliferative vitreoretinopathy: A pilot study 87
Dopamine, cognitive impairments and second-generation antipsychotics: From mechanistic advances to more personalized treatments 87
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 87
Long-term incubation with beta-amyloid peptides impairs endothelium-dependent vasodilatation in isolated rat basilar artery 86
Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System 86
Abnormal vascular responses and cerebral reperfusion injury in ApoE-deficient mice on Western diet 85
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 85
Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia gravis 85
Linking the Price of Cancer Drug Treatments to Their Clinical Value 84
Potential drug mechanism(s) targeting the contractile status of hepatic stellate cells 84
Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies. 83
Forehead Tremor: A Clinical Presentation of Myasthenia Gravis? 83
A THERAPEUTIC DOSAGE OF AMLODIPINE PREVENTS VASCULAR HYPOREACTIVITY INDUCED IN RATS BY LIPOPOLYSACCHARIDE 83
Asymmetry index of Blink Reflex Recovery Cycle differentiates Parkinson’s disease from atypical Parkinsonian syndromes 82
CALCIUM ANTAGONISTS AND ENDOTHELIAL FUNCTION: FOCUS ON NITRIC OXIDE AND ENDOTHELIN 81
Lipoprotein(a) serum levels in diabetic patients with retinopathy 81
Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas 81
Pericyte-like differentiation of human adipose-derived mesenchymal stem cells: An in vitro study 81
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 80
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 80
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 80
The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats 79
Exogenous nitric oxide mediates changes of vascular contractility induced by activated glia 79
Analytical and experimental pharmacology, challenges ahead 79
Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools 79
Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review 79
Early modulation of the endocannabinoid tone prevents molecular and behavioral alterations in MAM model of schizophrenia 78
Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors 77
Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011 77
Work Productivity and Activity Impairment in Colorectal Cancer Patients Treated with Capecitabine 77
Preclinical study of the action of a calcium channel blocker during salt load 75
Migraine: an overview 75
Preliminary pharmacokinetic and clinical evaluation of ofloxacin in dental and oral cavity diseases 74
Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network 74
Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1 73
Effects of PPARγ ligands on vascular tone 73
Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis 73
New pharmacological strategies for treatment of Alzheimer’s disease: focus on disease-modifying drugs 72
Action of the calcium channel blocker lacidipine on cardiac hypertrophy and endothelin-1 gene expression in stroke-prone hypertensive rats 72
Clinical pharmacology of novel anti-Alzheimer disease modifying medications. 72
Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats 71
INHIBITION BY BOSENTAN, AN ENDOTHELIN ANTAGONIST, OF THE HYPERSENSITIVITY TO CA2+ CHANNEL ACTIVATOR EVOKED BY SALT-LOADING IN BASILAR ARTERY OF STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS 70
Facilitation of the vasorelaxant action of calcium antagonists by basal nitric oxide in depolarized artery 69
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium 69
Centenarians and supercentenarians: a black swan. Emerging social, medical and surgical problems 68
An Italian Guidance Model for the Management of Suspected or Confirmed COVID-19 Patients in the Primary Care Setting 68
Totale 9.698
Categoria #
all - tutte 57.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.023


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.016 0 0 0 0 300 52 185 10 152 27 160 130
2021/20221.549 198 211 28 25 227 53 217 57 148 8 59 318
2022/20232.734 232 124 40 279 277 463 30 511 621 15 88 54
2023/2024992 60 149 54 73 36 208 17 62 8 17 187 121
2024/20254.022 51 626 214 248 911 464 115 174 297 389 282 251
2025/20263.018 463 365 1.550 521 119 0 0 0 0 0 0 0
Totale 15.436